Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of Refractory Autoimmune Encephalitis and Autoimmune Cerebellitis
Clinical trial NCT07686042 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07686042
- Sponsor
- Beijing Tiantan Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-24
- Primary completion
- 2028-12-31
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.